Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 20, 2025
T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 InfectionWenyan Fu, Wei Zhang, Zhongshuai You, et al.Environmental Toxicology and Pharmacology|March 21, 2015
In vitro cytotoxicity of gold nanorods in A549 cellsYing Tang, Yafeng Shen, Libin Huang, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 3, 2026
Phenolic-Rich Grape Exosome-Like Nanoparticles: Evidence of Multivesicular Body Pathway Secretion and Therapeutic Effect on Oral InflammationXinya Zheng, Hongru Ai, Fangxing Lin, et al.Journal of Drug Targeting|March 10, 2018
Cardiac adenovirus-associated viral Presenilin 1 gene delivery protects the left ventricular function of the heart via regulating RyR2 function in post-ischaemic heart failureTian Li, Yafeng Shen, Li Su, et al.Frontiers in Pharmacology|December 25, 2025
Protective effects of an Fc-engineered PD-L1 fusion protein in a spontaneous abortion model and a Th17 cell-induced pregnancy loss modelGuangyao Li, Tiantian Wang, Dan Tan, et al.Clinical Immunology (Orlando, Fla.)|April 22, 2019
Treatment of murine lupus with TIGIT-IgShuowu Liu, Lizhu Sun, Chuqi Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell FrequencyWenyan Fu, Changhai Lei, Yue Yu, et al.Science Translational Medicine|March 10, 2017
Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequencyShi Hu, Wenyan Fu, Tian Li, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2019
Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in ratsTian Li, Yafeng Shen, Fangxing Lin, et al.Molecular Immunology|May 23, 2017
Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibodyXiaojie Yu, Lingfei Wang, Yafeng Shen, et al.Pageof 4